IM Cannabis Corp. current report, Q4 FY2022

Business Context and Reporting Period

IM Cannabis Corp. filed a Form 6-K on November 14, 2022, covering the month of November 2022. The filing identifies exhibits relating to the company’s interim financial reporting for the three and nine months ended September 30, 2022.

Financial Metrics

The provided filing text contains only the Form 6-K cover page and exhibit index. It does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, assets, liabilities, or other financial metrics.

Material Changes Versus the Prior Comparable Period

The filing text does not include the interim financial statements or Management’s Discussion and Analysis, so material changes versus the prior comparable periods cannot be determined from the provided content.

Guidance, Outlook, Risks, and Unusual Items

No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided text. These matters may be addressed in the referenced exhibits but are not included here.

Important Facts to Verify

  • Review Exhibit 99.2 for the interim consolidated financial statements for the three and nine months ended September 30, 2022.
  • Review Exhibit 99.3 for management’s discussion of operating results, liquidity, capital resources, risks, and outlook.
  • Verify the company’s revenue, profitability, cash flow, debt, liquidity, and comparative-period changes using the complete exhibits.
  • Confirm the certifications in Exhibits 99.4 and 99.5, signed by the CFO and CEO, respectively.